Davos. The world’s elite gathering to discuss the future of the global economy. While some more conspiracy-minded folks might scoff at this gathering of top industry leaders, the fact remains that Davos is one of our more significant economic shindigs.
Which is why having psychedelic medicine at Davos is such an important milestone for the industry.
As world leaders come together to discuss the global economy at the World Economic Forum’s annual gathering, the world’s most prominent psychedelic industry leaders, drug development experts, clinicians, nonprofit organizations, advocates, and influencers will gather separately in Davos at the inaugural Medical Psychedelic Series to help shape the future of mental health.
Microdose was there, to speak and be part of this leadership group bringing psychedelic medicine to a broader audience, one that could help move the industry forward.
“It’s an honour to be a part of the first Medical Psychedelic House of Davos. The reception has been exceptional and the house has been one of the most popular spots on the promenade. It’s brought together world powers and thought leaders on the topic of psychedelic medicine and we’ve seen a positive shift in sentiment” — Connor Haslam, CEO Microdose
The inaugural week-long series is taking place from May 21-26, 2022
, at the Medical Psychedelics House of Davos located at Platzhirsch Club Davos, Promenade 63, 7270 Davos, Switzerland. The full program can be found here.
Hosted by Energia Holdings Incorporated, the series includes educational talks and panels featuring some of the best-known figures in the psychedelic space, including psychedelic researcher David Nichols, PhD; Endowed Professor & Vice Chair of Psychiatry, Icahn School of Medicine at Mount Sinai Rachel Yehuda, PhD and world-renowned founder of the Beckley Foundation Amanda Feilding. Acclaimed author and psychedelic medicine advocate Deepak Chopra and TV personality and advocate Jason Silva will also be speaking during the weeklong series. Over 40 key opinion leaders from all over the world will be participating in the event.
The majority of conversations at the Medical Psychedelics House of Davos will focus on regulatory approval for these compounds, their therapeutic potential, policy, safety and efficacy, biocultural preservation, drug development pipelines, and patient access.
It’s an honor for Microdose to be a continued part of the advancement of the industry and new solutions for mental health and wellness. Stay tuned for more.
